2016
DOI: 10.1007/s00109-016-1472-6
|View full text |Cite
|
Sign up to set email alerts
|

Deregulation of ocular nucleotide homeostasis in patients with diabetic retinopathy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
26
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
6
1

Relationship

3
4

Authors

Journals

citations
Cited by 26 publications
(27 citation statements)
references
References 50 publications
1
26
0
Order By: Relevance
“…Soluble NTPDase/ADPase, e N/CD73, ADA, and AK were assayed by incubating the VF (or serum) with [ 3 H]ADP, [ 3 H]AMP, [ 3 H]adenosine, and [ 3 H]AMP plus ATP, as respective enzyme substrates. 3 H-labeled nucleotides and nucleosides were separated by thin-layer chromatography (TLC) and quantified by scintillation β-counting [17, 25] or developed by autoradiography, as described in the Supplementary Material. In competitive assays, the samples were pretreated for 30 min with inhibitors of NTPDases sodium polyoxotungstate-1 (POM-1) (Tocris Bioscience, Bristol, UK) and POM-144 [26], selective e N/CD73 inhibitors α,β-methylene ADP (APCP, Sigma) and its derivative N 6 -phenylethyl-[(phosphonomethyl)-phosphonic acid], (PSB-12379 [27]), inhibitor of AK diadenosine pentaphosphate (Ap 5 A), and ADA inhibitor erythro-9-(2-hydroxy-3-nonyl)adenine hydrochloride (EHNA, Tocris Bioscience).…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…Soluble NTPDase/ADPase, e N/CD73, ADA, and AK were assayed by incubating the VF (or serum) with [ 3 H]ADP, [ 3 H]AMP, [ 3 H]adenosine, and [ 3 H]AMP plus ATP, as respective enzyme substrates. 3 H-labeled nucleotides and nucleosides were separated by thin-layer chromatography (TLC) and quantified by scintillation β-counting [17, 25] or developed by autoradiography, as described in the Supplementary Material. In competitive assays, the samples were pretreated for 30 min with inhibitors of NTPDases sodium polyoxotungstate-1 (POM-1) (Tocris Bioscience, Bristol, UK) and POM-144 [26], selective e N/CD73 inhibitors α,β-methylene ADP (APCP, Sigma) and its derivative N 6 -phenylethyl-[(phosphonomethyl)-phosphonic acid], (PSB-12379 [27]), inhibitor of AK diadenosine pentaphosphate (Ap 5 A), and ADA inhibitor erythro-9-(2-hydroxy-3-nonyl)adenine hydrochloride (EHNA, Tocris Bioscience).…”
Section: Methodsmentioning
confidence: 99%
“…A 2A and other subtypes of adenosine receptors were shown to be implicated in the modulation of the light responses of photoreceptors, retinal hyperemia, pathological retinal angiogenesis, protection of neurons from hyper-excitation and glutamate toxicity [3, 1013]. Previous research from our and other laboratories revealed the ability of VF and aqueous humor to maintain ATP and adenosine at certain characteristic nanomolar levels, which increase in pathological conditions, such as dry eye disease [14], glaucoma [2, 12, 15], age-related macular degeneration with subretinal hemorrhage [4], and diabetic retinopathy (DR) [16, 17].…”
Section: Introductionmentioning
confidence: 99%
“…thus, affected patients are often included as a control group in analyses of in ammation-related ocular diseases [9]. However, after onset of IMHs, tissue damage and reparation often lead to local in ammatory reactions, which affect cytokine levels in the aqueous humor.…”
Section: Discussionmentioning
confidence: 99%
“…One of the most recent study, demonstrate that AK1 from the human vitreous fluid is responsible for maintaining an inflammatory status in diabetic eyes (Fig. 3a) [37]. Also, the ATP, ADP, and AMP ratio is crucial in ocular diseases like age-related macular degeneration, glaucoma or retinal degeneration [38][39][40].…”
Section: Human Adenylate Kinases and Immunity And Inflammationmentioning
confidence: 97%